FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2406452656> ?p ?o ?g. }

• W2406452656 endingPage "1316" @default.
• W2406452656 startingPage "1308" @default.
• W2406452656 abstract "Objective: This study aims to compare the pharmacokinetics and oral bioavailability of a capsule combining 17β-estradiol and progesterone in a non–peanut oil–containing formulation with those of widely used and approved separate formulations of estradiol and progesterone coadministered to healthy postmenopausal women. Methods: This was an open-label, balanced, randomized, single-dose, two-treatment, three-period, three-sequence, cross-over, partial-replicate, reference-scaled study. Postmenopausal women (aged 40-65 y) were randomly assigned to one of three dosing sequences of test and reference products (TRR, RTR, or RRT, where T is the test drug and R is the coadministered reference product), with each of the three periods separated by a 14-day washout. The primary pharmacokinetic endpoints were Cmax, AUC(0-t), and AUC(0-inf) for the test and reference products, assessed for bioequivalence using the scaled average bioequivalence or unscaled average bioequivalence method. Safety was assessed by clinical observation, participant-reported adverse events, and laboratory data, including blood levels of hormones. Results: Sixty-six women were randomly assigned, and 62 women (94.0%) completed all three study periods. All AUC and Cmax parameters met bioequivalence criteria for all analytes (estradiol, progesterone, and estrone), except Cmax for total estrone. The extent of estradiol and progesterone absorption was similar between the test product and the reference products. Four adverse events—all considered mild and unrelated to the study drugs—were reported. Conclusions: The combination 17β-estradiol/progesterone product demonstrates bioavailability similar to those of the respective reference products of estradiol and progesterone. If regulatory approval is obtained, this new hormone therapy would be the first treatment of menopause symptoms to combine progesterone with 17β-estradiol in an oral formulation." @default.
• W2406452656 created "2016-06-24" @default.
• W2406452656 creator A5048706653 @default.
• W2406452656 creator A5071092589 @default.
• W2406452656 creator A5073409440 @default.
• W2406452656 creator A5086631086 @default.
• W2406452656 creator A5087111403 @default.
• W2406452656 date "2015-12-01" @default.
• W2406452656 modified "2023-10-18" @default.
• W2406452656 title "Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy" @default.
• W2406452656 cites W1593442063 @default.
• W2406452656 cites W1986009920 @default.
• W2406452656 cites W2009559741 @default.
• W2406452656 cites W2009839837 @default.
• W2406452656 cites W2012217734 @default.
• W2406452656 cites W2017639777 @default.
• W2406452656 cites W2033756945 @default.
• W2406452656 cites W2042641945 @default.
• W2406452656 cites W2045587972 @default.
• W2406452656 cites W2051036015 @default.
• W2406452656 cites W2066058725 @default.
• W2406452656 cites W2072831812 @default.
• W2406452656 cites W2089383847 @default.
• W2406452656 cites W2104231345 @default.
• W2406452656 cites W2108479208 @default.
• W2406452656 cites W2112457093 @default.
• W2406452656 cites W2119743410 @default.
• W2406452656 cites W2120754250 @default.
• W2406452656 cites W2123511777 @default.
• W2406452656 cites W2134335588 @default.
• W2406452656 cites W2140244607 @default.
• W2406452656 cites W2149049017 @default.
• W2406452656 cites W2172094497 @default.
• W2406452656 cites W2321923392 @default.
• W2406452656 cites W4206077173 @default.
• W2406452656 cites W4246052774 @default.
• W2406452656 cites W4285719527 @default.
• W2406452656 cites W4294915367 @default.
• W2406452656 cites W2278104485 @default.
• W2406452656 doi "https://doi.org/10.1097/gme.0000000000000467" @default.
• W2406452656 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4666011" @default.
• W2406452656 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25944519" @default.
• W2406452656 hasPublicationYear "2015" @default.
• W2406452656 type Work @default.
• W2406452656 sameAs 2406452656 @default.
• W2406452656 citedByCount "14" @default.
• W2406452656 countsByYear W24064526562016 @default.
• W2406452656 countsByYear W24064526562017 @default.
• W2406452656 countsByYear W24064526562018 @default.
• W2406452656 countsByYear W24064526562019 @default.
• W2406452656 countsByYear W24064526562020 @default.
• W2406452656 countsByYear W24064526562022 @default.
• W2406452656 countsByYear W24064526562023 @default.
• W2406452656 crossrefType "journal-article" @default.
• W2406452656 hasAuthorship W2406452656A5048706653 @default.
• W2406452656 hasAuthorship W2406452656A5071092589 @default.
• W2406452656 hasAuthorship W2406452656A5073409440 @default.
• W2406452656 hasAuthorship W2406452656A5086631086 @default.
• W2406452656 hasAuthorship W2406452656A5087111403 @default.
• W2406452656 hasBestOaLocation W24064526561 @default.
• W2406452656 hasConcept C112705442 @default.
• W2406452656 hasConcept C126322002 @default.
• W2406452656 hasConcept C141071460 @default.
• W2406452656 hasConcept C142724271 @default.
• W2406452656 hasConcept C181389837 @default.
• W2406452656 hasConcept C197934379 @default.
• W2406452656 hasConcept C204787440 @default.
• W2406452656 hasConcept C22979827 @default.
• W2406452656 hasConcept C27081682 @default.
• W2406452656 hasConcept C2777288759 @default.
• W2406452656 hasConcept C2777744392 @default.
• W2406452656 hasConcept C2777956591 @default.
• W2406452656 hasConcept C2778656385 @default.
• W2406452656 hasConcept C2778723060 @default.
• W2406452656 hasConcept C2908647359 @default.
• W2406452656 hasConcept C2986817661 @default.
• W2406452656 hasConcept C42404028 @default.
• W2406452656 hasConcept C71315377 @default.
• W2406452656 hasConcept C71924100 @default.
• W2406452656 hasConcept C87813604 @default.
• W2406452656 hasConcept C98274493 @default.
• W2406452656 hasConcept C99454951 @default.
• W2406452656 hasConceptScore W2406452656C112705442 @default.
• W2406452656 hasConceptScore W2406452656C126322002 @default.
• W2406452656 hasConceptScore W2406452656C141071460 @default.
• W2406452656 hasConceptScore W2406452656C142724271 @default.
• W2406452656 hasConceptScore W2406452656C181389837 @default.
• W2406452656 hasConceptScore W2406452656C197934379 @default.
• W2406452656 hasConceptScore W2406452656C204787440 @default.
• W2406452656 hasConceptScore W2406452656C22979827 @default.
• W2406452656 hasConceptScore W2406452656C27081682 @default.
• W2406452656 hasConceptScore W2406452656C2777288759 @default.
• W2406452656 hasConceptScore W2406452656C2777744392 @default.
• W2406452656 hasConceptScore W2406452656C2777956591 @default.
• W2406452656 hasConceptScore W2406452656C2778656385 @default.
• W2406452656 hasConceptScore W2406452656C2778723060 @default.
• W2406452656 hasConceptScore W2406452656C2908647359 @default.
• W2406452656 hasConceptScore W2406452656C2986817661 @default.

• next